ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0079240 | null | Technic, Dilution|dilution|Dilution Technic|Dilution Techniques|Dilution Technique|dilutions|Dilution|Dilution (qualifier value)|Technique, Dilution|Dilution Technics|Technics, Dilution|Techniques, Dilution | Dilution technique |
C0997342 | null | Glomus intraradices | Rhizophagus intraradices |
C0445951 | A species of anaerobic, Gram negative, rod shaped bacterium assigned to the phylum Proteobacteria. This species is motile by single polar flagellum, reduces sulfate and is catalase positive. D. desulfuricans is an infrequent pathogen and may be important in manufacturing for the bioreduction of metals including Uranium and Palladium. Phenotypically, it is indistinguishable from Desulfovibrio fairfieldensis. | Spirillum desulfuricans|DESULFOVIBRIO DESULFURICANS|Desulfovibrio desulfuricans|Bacillus desulfuricans|Vibrio cholinicus|Desulfovibrio desulfuricans (organism)|Microspira desulfuricans | Desulfovibrio desulfuricans |
C1499971 | null | null | Phaffia rhodozyma |
C0052565 | Carotenoid having a chemical structure similar to beta-carotene with hydroxyl groups at the number 3 and 3' carbon atoms and carbonyl (C=O) functions at the number 4 and 4' carbon atoms. | ASTAXANTHIN|astaxanthine|Astaxanthin|(3S,3'S)-3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione|Astaxanthin (substance)|Astaxanthine|3,3'-dihydroxy-beta-carotene-4,4'-dione|astaxanthin | astaxanthin |
C0060562 | null | Fluoromethane|methyl fluoride|Fluoromethane (substance) | fluoromethane |
C0596577 | A group of phenyl benzopyrans named for having structures like FLAVONES. | Flavonoid (substance)|2 Phenyl Benzopyrans|Flavonoid-containing product|2 Phenyl Chromenes|Flavonoid|Flavonoids|2-Phenyl-Benzopyrans|flavonoids|2-Phenyl-Chromenes|flavonoid|Product containing flavonoid (product) | Flavonoids |
C0001771 | A complex sulfated polymer of galactose units, extracted from Gelidium cartilagineum, Gracilaria confervoides, and related red algae. It is used as a gel in the preparation of solid culture media for microorganisms, as a bulk laxative, in making emulsions, and as a supporting medium for immunodiffusion and immunoelectrophoresis. | Agar, Unspecified|agars|agar, unspecified|Agar, unspecified|Agar (substance)|agar|Agar|AGAR, UNSPECIFIED|AGAR | agar |
C0303848 | null | Organic sulphur compound|Organic sulfur compound (substance)|Organic Sulfur Compounds|Organic Sulfur Compound|Organosulfur compound|Organic sulfur compound|Organosulphur compound|Organic sulfur compound, NOS|organic sulfur compounds|ORGANIC SULFUR COMPOUNDS | Organic sulfur compound |
C0020282 | A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed) | Hydrogen sulfide (substance)|Hydrogen sulfide (H2S)|Hydrogen sulfide|Sulfur hydride|Hydrogen Sulfide|hydrogen sulphide|Sulfide, Hydrogen|hydrogen sulfide | Hydrogen Sulfide |
C0028429 | A part of the upper respiratory tract. It contains the organ of SMELL. The term includes the external nose, the nasal cavity, and the PARANASAL SINUSES. | NOSE|Nasus|nose|nasals|nasal|Naso-|Nasal|nasal structure|Nose|Nasal structure|Nose (Nasal Passage)|Noses|Nasal structure (body structure)|Nasal (qualifier value)|Nose, NOS|Rhino-|NASAL|noses | Nose |
C0751987 | A class in the phylum PROTEOBACTERIA comprised of chemoheterotrophs and chemoautotrophs which derive nutrients from decomposition of organic material. | beta proteobacteria|Class Betaproteobacteria|Class Betaproteobacteria (organism)|beta Proteobacteria|Betaproteobacteria|Proteobacteria beta subdivision|Purple bacteria, beta subdivision|Proteobacteria beta|beta subgroup|beta subdivision | Betaproteobacteria |
C1034493 | A taxonomic family of gram negative, aerobic bacterium in the phylum Proteobacteria that includes the genera Acidovorax, Comamonas, Delftia and Pelomonas, among others. | Family Comamonadaceae (organism)|Comamonadaceae|beta-1 subgroup|Family Comamonadaceae | Comamonadaceae |
C1310461 | null | Nei-like-2 protein, human|NEH2 protein, human|nei like 2 (E. coli) protein, human | NEIL2 protein, human |
C1310461 | null | Nei-like-2 protein, human|NEH2 protein, human|nei like 2 (E. coli) protein, human | NEIL2 protein, human |
C1444090 | null | Antimicrobial resistant bacteria (organism)|Antibacterial agent resistant bacteria|Antimicrobial resistant bacteria | Resistant bacteria |
C0059171 | null | FokI endonuclease | endodeoxyribonuclease FokI |
C0333262 | An abnormal fluid-filled cleft (e.g. as in the epidermis) or membrane-bound space. | VESICLES|vesicle|VESICLE|Vesicle|vesicles|Vesicle formation|Vesicle (morphologic abnormality) | Vesicle (morphologic abnormality) |
C0079835 | Microscopy in which the samples are first stained immunocytochemically and then examined using an electron microscope. Immunoelectron microscopy is used extensively in diagnostic virology as part of very sensitive immunoassays. | Microscopies, Immunoelectron|Immuno-Electron Microscopy|Immunoelectron Microscopies|Immuno-Electron Microscopies|Microscopy, Immuno Electron|Immunoelectron Microscopy|immunoelectron microscopy|Microscopy, Immuno-Electron|Microscopies, Immuno-Electron | Microscopy, Immunoelectron |
C0205111 | Relating to or located at the tip (an apex). | apical|Apical|APICAL|Apical (qualifier value) | Apical |
C1159599 | The directed movement of phosphate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. [GOC:krc] | phosphate transport | phosphate ion transport |
C0074299 | A substance that contains the element selenium (a nutrient that protects cells against damage) and is found in certain plants such as garlic and broccoli. Se-methyl-seleno-L-cysteine can act as an antioxidant and may help prevent or slow the growth of cancer cells. It is a type of amino acid. | Se-methylselenocysteine|selenomethylselenocysteine|Se-methyl-seleno-L-cysteine|Se-Methyl-seleno-L-cysteine|SeMCys|Selenium-methylselenocystine|3-(Methylseleno)-l-alanine|l-Se-Methylselenocysteine|MSC|3-(methylseleno)-l-alanine|methyl selenocysteine|selenohomocysteine|Se-Methylselenocysteine|SE-METHYL-SELENO-L-CYSTEINE|3-(methylseleno)alanine|methylselenocysteine|Methylselenocycteine|L-Se-Methylselenocysteine|SeMSC|l-se-methylselenocysteine|Methylselenocysteine|Se-methyl-selenocysteine|selenium-methylselenocystine | selenomethylselenocysteine |
C0338237 | Treatment of bacterial infections with antibiotics. | Antibiotic Therapy|antibiotic therapy|Antibiotic therapy|antibiotics therapy|therapy antibiotic|Treatment of Bacterial Infectious Disease|Antibiotic therapy (procedure)|therapy, antibiotic | Antibiotic therapy |
C0149725 | An acute or chronic, viral or bacterial infectious process that affects the lower respiratory tract. | CHEST INFECTION|chest colds|Lower Respiratory Infection|lower respiratory infection|Lower respiratory infection, NOS|cold chest|Lower respiratory tract infection (disorder)|Chest cold, NOS|Lower respiratory tract infections|Lower respiratory tract infection, NOS|Lower respiratory tract infection|Lower respiratory tract infectious disease|Lower respiratory infection|lrti|LOWER RESPIRATORY INFECTION|LRTI - Lower respiratory tract infection|Chest cold|infections lower respiratory|chest cold|Lower Respiratory Tract Infection | Lower respiratory tract infection |
C1518010 | Radiotherapy using radioactive particles that deposit a low amount of energy by radiation per unit length of travel. | Low Dose Radiation | Low Dose Radiation Therapy |
C1266091 | A thymic epithelial neoplasm characterized by the presence of spindle and/or oval neoplastic epithelial cells. Lymphocytic infiltration is minimal or absent. It may be associated with myasthenia gravis or pure red cell aplasia. The majority of cases occur in the anterior mediastinum as Masaoka stage I tumors. Approximately 20% of the cases occur as stage II or stage III tumors. Type A thymoma generally behaves as a benign tumor and the overall survival is reported to be 100% at 5 and 10 years. | medullary thymoma|Thymoma, type A (morphologic abnormality)|Spindle Cell Thymoma|type A thymoma|Thymoma, medullary|Medullary Thymoma|Thymoma, spindle cell|spindle cell thymoma|Thymoma Type A | Thymoma, type A |
C0002880 | Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS. | Haemolytic Anaemia, Autoimmune|Hemolytic Anemia, Autoimmune|anaemia haemolytic autoimmune|Autoimmune Haemolytic Anaemia|Autoimmune hemolytic anemia (disorder)|hemolytic autoimmune anemia|Autoimmune Hemolytic Anemia|Anemia, Hemolytic, Autoimmune|Autoimmune haemolytic anaemia, NOS|autoimmune hemolytic anemia|anemia hemolytic autoimmune|Anaemia, Autoimmune Haemolytic|Anemia, Autoimmune Hemolytic|Autoimmune hemolytic anemia|Hemolytic anemia due to antibody, NOS|Haemolytic anaemia due to antibody, NOS|ANEMIA HEMOLYTIC AUTOIMMUNE (NOS)|Hemolytic anemia, autoimmune|ANEMIA, AUTOIMMUNE HEMOLYTIC|autoimmune haemolytic anaemia|Autoimmune Hemolytic Anemias|Autoimmune hemolytic anemias|Hemolytic anemia, Autoimmune|autoimmune haemolytic anaemias|Autoimmune hemolytic anemia, NOS|autoimmune hemolytic anemias|Autoimmune Haemolytic Anaemias|immunohemolytic anemia|Immune mediated hemolytic anemia|anemia autoimmune hemolytic|Autoimmune haemolytic anaemia | Autoimmune hemolytic anemia |
C0030807 | Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS. | PEMPHIGUS|Pemphigus|Pemphigus, NOS|Pemphigus NOS|pemphigus|Pemphigus (disorder) | Pemphigus |
C0230694 | A rod shaped cytoplasmic organelle found in Langerhans cells of the epidermis. | Langerhans' granule|Langerhans' granule (cell structure)|Langerhan's cell granule|Vermiform granule|Birbeck Granule|Birbeck granule|birbeck granule|birbeck granules | Langerhans' granule |
C0077066 | null | Wheatly stain|Wheatley's stain|Trichrome stain (substance)|Wheatley stain|Wheatley's formulation|trichrome stain|Trichrome stain | Trichrome stain |
C0752265 | Extracellular matrix components occurring independently or along with elastin. Thought to have force-bearing functions in tendon. In addition to fibrillins, microfibrils may contain other associated proteins. [PMID:27026396] | microfibril|Microfibril|extended fibrils | Microfibrils |
C0042232 | The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed) | Vagina, NOS|vaginal|Vagina|Vagino-|birth canal|vaginas|Vaginal structure|vaginal structure|Genital System, Female, Vagina|VAGINA|vagina|Vaginal structure (body structure)|Vagina/Vaginal|Vaginal|Vaginas | Vagina |
C0221909 | A simple or stratified flat epithelium. | Squamous epithelial tissue|Squamous epithelium (body structure)|squamous epithelium|Squamous Epithelium|Squamous epithelium, NOS | Squamous epithelium |
C0032333 | Caustic extract from the roots of Podophyllum peltatum and P. emodi. It contains PODOPHYLLOTOXIN and its congeners and is very irritating to mucous membranes and skin. Podophyllin is a violent purgative that may cause CNS damage and teratogenesis. It is used as a paint for warts, skin neoplasms, and senile keratoses. | Resin, Podophyllum|Podophyllin|podophyllum resin|Product containing Podophyllum resin (medicinal product)|Podophyllum resin|Podophyllum (resin)|PODOPHYLLIN|Podophyllum resin-containing product|Mayapple Extract|podophyllin|PODOPHYLLUM RESIN|Podophyllum resin (substance)|Podophyllum Resin|Podofillina|Podophyllin Resin | podophyllin |
C0032333 | Caustic extract from the roots of Podophyllum peltatum and P. emodi. It contains PODOPHYLLOTOXIN and its congeners and is very irritating to mucous membranes and skin. Podophyllin is a violent purgative that may cause CNS damage and teratogenesis. It is used as a paint for warts, skin neoplasms, and senile keratoses. | Resin, Podophyllum|Podophyllin|podophyllum resin|Product containing Podophyllum resin (medicinal product)|Podophyllum resin|Podophyllum (resin)|PODOPHYLLIN|Podophyllum resin-containing product|Mayapple Extract|podophyllin|PODOPHYLLUM RESIN|Podophyllum resin (substance)|Podophyllum Resin|Podofillina|Podophyllin Resin | podophyllin |
C0040162 | A tripeptide that stimulates the release of THYROTROPIN and PROLACTIN. It is synthesized by the neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, TRH (was called TRF) stimulates the release of TSH and PRL from the ANTERIOR PITUITARY GLAND. | Thyrotropin releasing factor (substance)|PROTIRELIN|Thyrotropin releasing hormone preparation|TSH-releasing hormone|Thyrotropin-releasing factor|pyroGlu-His-Pro-NH2 (or 5-oxo-L-prolyl-L-histidyl-L-prolinamide)|trh|thyrotrophin releasing hormone|Thyrotropin releasing hormone|protirelin|Protirelina|TRH - Thyrotrophin releasing hormone|Thyrotropic releasing hormone|Product containing thyrotropin releasing factor (medicinal product)|Thyrotropin Releasing Hormone|thyrotropin-releasing hormone|thyrotropin RH|Thyrotropin Releasing Factor|Thyrotropin releasing factor (TRF)|Thyrotropin-Releasing Hormone|TSH-releasing factor|Thyrotrophin releasing hormone|thyrotropin releasing hormone|TRH|Protirelin-containing product|5-oxo-L-prolyl-L-histidyl-L-prolinamide|Thyrotropic-releasing factor|Protirelin (substance)|Thyrotropin releasing factor-containing product|L-pyroglutamyl-L-histidyl-L-prolineamide|Protirelin preparation|Thyrotropin releasing factor|thyrotropin releasing hormone (TRH)|Product containing protirelin (medicinal product)|Thyrotropin-Releasing Factor|TRF|Protirelin | thyrotropin-releasing hormone |
C0003372 | Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION. | Antilymphocyte serum|Serum, Antilymphocyte|Antilymphocyte Globulin|ALG|Antilymphocyte Serums|antilymphocyte serum|Serums, Antilymphocyte|Antilymphocyte Serum|ALS | Antilymphocyte Serum |
C0809909 | null | null | Salyrgan |
C0200706 | null | Sedimentation rate, Wintrobe|Sedimentation rate, Wintrobe (procedure) | Sedimentation rate, Wintrobe |
C0019054 | The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. | Hemolysis|HAEMOLYSIS|Haemolysis|Haemolyses|HEMOLYSIS | Hemolysis (disorder) |
C0181209 | null | Hook (attribute)|hooks|hooking|hooked|hook | Hook |
C0027575 | A species of gram-negative, aerobic BACTERIA. It is a commensal and pathogen only of humans, and can be carried asymptomatically in the NASOPHARYNX. When found in cerebrospinal fluid it is the causative agent of cerebrospinal meningitis (MENINGITIS, MENINGOCOCCAL). It is also found in venereal discharges and blood. There are at least 13 serogroups based on antigenic differences in the capsular polysaccharides; the ones causing most meningitis infections being A, B, C, Y, and W-135. Each serogroup can be further classified by serotype, serosubtype, and immunotype. | Meningococcus|n. meningitidis|Diplokokkus intracellularis meningitidis|Micrococcus meningitidis|Neisseria meningitidis|Beta-Lactamase Negative Neisseria meningitidis|Neisseria weichselbaumii|neisseria meningitidis|meningococcus|Micrococcus intracellularis|NEISSERIA MENINGITIDIS|Micrococcus meningitidis cerebrospinalis|meningitidis n|N. meningitidis|Neisseria meningitidis (organism)|Neisseria intracellularis|meningitidis neisseria | Neisseria meningitidis |
C0038402 | A genus of gram-positive, coccoid bacteria whose organisms occur in pairs or chains. No endospores are produced. Many species exist as commensals or parasites on man or animals with some being highly pathogenic. A few species are saprophytes and occur in the natural environment. | Genus Streptococcus (organism)|Streptococcus|Streptococcus, NOS|streptococcus organism|streptococcus bacteria|streptococcus|STREPTOCOCCUS|Streptococci sp.|Streptococcal|Genus Streptococcus | Streptococcus |
C0038174 | A species of STAPHYLOCOCCUS that is a spherical, non-motile, gram-positive, chemoorganotrophic, facultative anaerobe. Mainly found on the skin and mucous membrane of warm-blooded animals, it can be primary pathogen or secondary invader. | staphylococcus epidermidis|Micrococcus pyogenes var. albus|s. epidermidis|S. epidermidis|Staphylococcus epidermidis (organism)|Staphylococcus epidermidis|staphylococcus epidermidis albus|Micrococcus epidermidis|Staphylococcus albus|Staphylococcus epidermidis albus|Albococcus epidermidis|staphylococcus albus|STAPHYLOCOCCUS EPIDERMIDIS | Staphylococcus epidermidis |
C0055019 | null | Celestine blue B|C.I. mordant blue 14|Celestine Blue|1-carbamoyl-7-(diethylamino)-3,4-dihydroxyphenoxazinium chloride|Mordant blue 14|celestine Blue B|Celestine blue B stain (substance)|Coelestine blue|Celestine blue B stain|Celestine blue|Coelestine blue B stain | Celestine Blue |
C0055538 | Proteins that bind to and transfer CHOLESTEROL ESTERS between LIPOPROTEINS such as LOW-DENSITY LIPOPROTEINS and HIGH-DENSITY LIPOPROTEINS. | Cholesterol Ester Transport Protein, CETP|Cholesterol ester transfer protein (substance)|cholesteryl ester transfer protein|Cholesteryl Ester Exchange Protein|Cholesterol ester transfer protein|Cholesterol Ester Transfer Proteins|Cholesteryl Ester Transfer Protein | Cholesterol Ester Transfer Proteins |
C1141071 | null | null | Sodium Chloride 180 MG |
C1141071 | null | null | Sodium Chloride 180 MG |
C0008240 | A naturally occurring phenolic acid which is a carcinogenic inhibitor. It has also been shown to prevent paraquat-induced oxidative stress in rats. (From J Chromatogr A 1996;741(2):223-31; Biosci Biotechnol Biochem 1996;60(5):765-68). | 3-caffeoylquinic acid|chlorogenic acid|acid chlorogenic|CHLOROGENIC ACID|5-O-(3,4-Dihydroxycinnamoyl)-L-quinic Acid|5-O-(3,4-dihydroxycinnamoyl)-L-quinic acid|3-Caffeoylquinic Acid|Chlorogenic acid|Acid, 3-Caffeoylquinic|Acid, Chlorogenic|Cyclohexanecarboxylic acid, 3-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-1,4,5-trihydroxy-, (1S-(1alpha,3beta,4alpha,5alpha))-|3 Caffeoylquinic Acid|Chlorogenic Acid | chlorogenic acid |
C0019340 | Any inflammatory skin disease caused by a herpesvirus and characterized by the formation of small vesicles in clusters. | herpes|Herpes|HERPES | Herpes |
C0067762 | An N-acyl derivative of neuraminic acid. N-acetylneuraminic acid occurs in many polysaccharides, glycoproteins, and glycolipids in animals and bacteria. (From Dorland, 28th ed, p1518) | Sialic acid, NOS|Acid, Sialic|n-Acetyl neuraminic acid (substance)|N Acetylneuraminic Acid|n-acetylneuraminic acid|Sialic Acid|sialic acid|N-Acetylneuraminic Acid|n-Acetyl neuraminic acid|N-acetylneuraminic acid|Sialic acid|Acid, N-Acetylneuraminic | N-Acetylneuraminic Acid |
C1443650 | null | Substance with neuraminidase inhibitor mechanism of action|Substance with neuraminidase inhibitor mechanism of action (substance)|Neuraminidase inhibitor-containing product|Neuraminidase inhibitor|Product containing neuraminidase inhibitor (product) | Neuraminidase inhibitor |
C1154689 | The directed movement of a drug, a substance used in the diagnosis, treatment or prevention of a disease, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. [GOC:ai] | drug transport|Drug Transport|drugs transport | Drug Transport Process |
C0016411 | Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) | Folic Acid Antagonist|folic acid antagonists|antifolates|Antifolate (substance)|Folic acid--Antagonists|Acid Antagonists, Folic|Product containing antifolate (product)|Folic Acid Antagonists|antagonists folate|Antifolate-containing product|antifolate|Antagonists, Folic Acid|folic acid antagonist|Folate Antagonist|Antifolates|Antifolate|folate antagonist|Folate Analog|Folic Acid Inhibitors|Folate Inhibitors|Folic Acid Analog | Folic Acid Antagonists |
C0013203 | Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. | Drug Resistance|Drug resistance, NOS|Drug resistance (disorder)|Refractory drug response|Resistance, Drug|resistance drug|Drug resistance NOS|Drug Resistance Process|drugs resistance|Drug resistance|drug resistance | Drug resistance |
C0003419 | Drugs that are used to reduce body temperature in fever. | Antipyretic Agents|Agents, Antifebrile|Antipyretics|Agents, Antipyretic|antipyretic|Antifebrile Agents|Antipyretic, NOS|antipyretic drugs|antipyretics|ANTIPYRETICS|antipyretic drug | Antipyretics |
C0019592 | Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. | h1 antihistamine|Histamine H1 receptor antagonist-containing product|Blockaders, Histamine H1 Receptor|H1 blockers|Product containing histamine H1 receptor antagonist (product)|Histamine H1 Receptor Blockaders|h1 blockers|H1 Antagonists, Histamine|antihistaminic h1|Substance with histamine H1 receptor antagonist mechanism of action (substance)|h1 blocker|Antagonists, Histamine H1 Receptor|antihistamine h1|Antagonists, Histamine H1|histamine H1 receptor blockaders|H1 Receptor Blockaders|H1 Antihistaminics|Histamine H1 receptor antagonist|H-1 Receptor Antagonist|Histamine H1 Blockers|antihistamines h1|Antihistamine|Receptor Blockaders, H1|Histamine H1 Receptor Antagonists|Substance with histamine H1 receptor antagonist mechanism of action|antihistamine|Histamine H1 Antagonists|Antihistaminics, H1|Histamine-1 Receptor Antagonist | Histamine H1 Antagonists |
C0003290 | Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. | tricyclic antidepressant|tricyclic antidepressants|antidepressant drug tricyclic|Tricyclic antidepressant (product)|tricyclic antidepressive agents|Tricyclic antidepressant|Antidepressants, Tricyclic|tricyclic anti depressant|Drugs, Tricyclic Antidepressant|Tricyclic antidepressant (substance)|anti depressants tricyclic|TRICYCLIC ANTIDEPRESSANTS|Antidepressive Agents, Tricyclic|Tricyclic Antidepressant|Tricyclic Antidepressive Agents|antidepressants tricyclics|Tricyclic antidepressants|Tricyclic Antidepressant Drugs|Tricyclic Antidepressants|Antidepressant Drugs, Tricyclic|tricyclic anti-depressants|antidepressants tricyclic|anti depressant tricyclic|Tricyclics|Tricyclic antidepressant, NOS|tricyclic antidepressant drugs|Agents, Tricyclic Antidepressive | Tricyclic Antidepressive Agents |
C0040627 | Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins. | Transactivator|trans acting factor (genetic)|Trans Activator|Trans Acting Factor|Transactivators|Trans Acting Factors|Trans-Activator|Factor, Trans-Acting|trans acting factor|Trans Activators|Trans-Acting Factors|Trans-Acting Factor|Factors, Trans-Acting | Trans-Activators |
C0033931 | A group of disorders characterized by physical symptoms that are affected by emotional factors and involve a single organ system, usually under AUTONOMIC NERVOUS SYSTEM control. (American Psychiatric Glossary, 1988) | Psychophysiologic disorder NOS|Psychophysiologic disorder|psychophysiologic disorder|Psychosomatic disease|illnesses psychosomatic|Psychophysiologic Disorder|psychosomatic illness|Psychosomatic disorder NOS|Psychophysiologic disorder, NOS|Psychophysiological Disorder|psychosomatic disorders|disease psychosomatics|diseases psychosomatic|Psychophysiologic Disorders|psychophysiological dysfunction|Psychosomatic Disorders|Psychophysiological Disorders|illness psychosomatic|Psychosomatic disorder, NOS|psychophysiological disorders|psychosomatic disease|Psychophysiologic disorder (finding)|psychophysiologic disorders|Psychosomatic disorder|psychophysiological disorder|Psychosomatic Disorder|psychosomatic disorder | Psychophysiologic Disorders |
C0520963 | null | Diffuse pain|Diffuse pain (finding)|diffuse pain | Diffuse pain |
C0025023 | A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES. | MBDZ|Mebendazole-containing product|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Product containing mebendazole (medicinal product)|Mebendazole|Mebendazole (substance)|Mébendazole|Methyl 5-benzoyl benzimidazole-2-carbamate|(5-Benzoyl-1H-benzimidazol-2-yl)-carbamic Acid Methyl Ester|MEBENDAZOLE|Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester|mebendazole|Mebendazolum | mebendazole |
C0038463 | Infection with nematodes of the genus STRONGYLOIDES. The presence of larvae may produce pneumonitis and the presence of adult worms in the intestine could lead to moderate to severe diarrhea. | Strongyloidiases|Infection by Strongyloides|STRONGYLOIDOSIS|strongylodiasis|Strongyloidosis|Infection caused by Strongyloides (disorder)|strongyloidiasis|strongyloides infection|Infection by Strongyloides, NOS|Strongyloidiasis|STRONGYLOIDIASIS|Infection caused by Strongyloides|strongyloidosis | Strongyloidiasis |
C0014457 | Abnormal increase of EOSINOPHILS in the blood, tissues or organs. | high eosinophil count|High blood eosinophil count|EOSINOPHILIA|Increased eosinophils|increased eosinophils|eosinophils increased|EOSINOPHILIAS|EOSINOPHILS INCREASED|eosinophilia|Eosinophilia|eosinophilias|Eosinophilic leukocytosis|Eosinophilia, NOS|Eosinophilias | Eosinophilia |
C0042890 | Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body. | Vitamin preparation, NOS|VITAMINS: MISCELLANEOUS PREPARATIONS|vitamin|Vitamin, NOS|vitamins|VITAMINS|VITAMIN PREPARATIONS|Vitamin (substance)|Vitamin|Vitamin Preparations|Vitamins | Vitamins |
C0010481 | A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. | Cushing Syndrome|Cushing syndrome|Cushing's basophilism|CUSHING'S SYNDROME|SYNDROME CUSHING'S|Itsenko-Cushing syndrome|Suprarenogenic syndrome|pituitary basophilism|Syndrome, Cushing's|Hypercortisolism|cushing syndrome|CUSHINGS SYNDROME|Syndrome, Cushing|Cortisol Excess|Cushing's Syndrome|CUSHING SYNDROME|Cushing's syndrome III|Itsenko disease|Cushing's syndrome|Cushing's syndrome NOS|cushing's syndrome | Cushing Syndrome |
C0206667 | A benign neoplasm of the ADRENAL CORTEX. It is characterized by a well-defined nodular lesion, usually less than 2.5 cm. Most adrenocortical adenomas are nonfunctional. The functional ones are yellow and contain LIPIDS. Depending on the cell type or cortical zone involved, they may produce ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE. | ADENOMA ADRENAL|Adrenal cortical adenoma|Adenoma of Adrenal Cortex|Adrenal cortical adenoma morphology|Adrenal cortical adenoma, NOS|Benign Adrenal Gland Adenoma|adrenal adenoma|Adrenal adenoma (disorder)|Benign Adenoma of the Adrenal Gland|adenoma adrenal cortical|adenoma adrenal|Adrenal Adenoma|ADENOMA, ADRENOCORTICAL, BENIGN|Adenomas, Adrenocortical|Adrenocortical Adenomas|Adrenocortical adenomas|Adrenal Cortex Adenoma|ADRENAL CORTEX, ADENOMA|Adrenocortical adenoma|ADRENAL ADENOMA|Adrenocortical Adenoma|Adrenal cortical adenoma, no International Classification of Diseases for Oncology subtype|Benign Adenoma of Adrenal Gland|Adrenal adenoma|BENIGN ADRENAL ADENOMA|Adenoma, Adrenal Cortical|Adenoma of the Adrenal Gland|adenomas adrenal|Benign Adrenal Adenoma|Adrenal cortical adenoma, no International Classification of Diseases for Oncology subtype (morphologic abnormality)|adrenocortical adenoma|Cortical Cell Adenoma|Adrenal cortical adenoma, no ICD-O subtype|Adenomas, Adrenal Cortical|Adenoma of Adrenal Gland|Adrenal Cortical Adenomas|Adenoma, Adrenocortical|Adenoma of the Adrenal Cortex|Adrenal cortical adenoma (disorder)|adenoma adrenal cortex|Adrenal Cortical Adenoma|adrenal cortical adenoma|Adrenal Gland Adenoma | Adrenal Cortical Adenoma |
C0005974 | Bone loss due to osteoclastic activity. | Osteoclastic Bone Loss|Resorption, Bone|Bone resorption, NOS|Bone Loss, Osteoclastic|Resorptions, Bone|Losses, Osteoclastic Bone|Loss, Osteoclastic Bone|Bone resorption, function (observable entity)|bone resorption|Bone Resorptions|Osteoclastic Bone Losses|osteoclastic bone loss|Bone resorption|Bone Losses, Osteoclastic|Bone resorption, function | Bone Resorption |
C0035435 | Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement. | Rheumatic Diseases|rheumatic diseases|rheumatism|Rheumatism|Locomotor pain disorder|rheumatics|Diseases, Rheumatic|Rheumatism (disorder)|Disease, Rheumatic|Rheumatic Disease|Rheumatism, NOS|rheumatic disease|Musculoskeletal pain disorder | Rheumatism |
C0003873 | A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. | Arthritis or polyarthritis, atrophic|atrophic arthritis|ARTHRITIS, RHEUMATIC|Chronic rheumatic arthritis|Arthritis, rheumatic|ARTHRITIS RHEUMATOID|Rheumatoid disease|Atrophic arthritis|rheumatoid arthritis systemic|Rheumatoid arthritis (disorder)|RHEUMATOID ARTHRITIS|Rheumatoid Arthritis|Arthritis, Rheumatoid|RhA - Rheumatoid arthritis|ARTHRITIS, RHEUMATOID|Arthritis or polyarthritis, rheumatic|proliferative arthritis|Rheumatic gout|rheumatoid arthritis|gout rheumatic|RA - Rheumatoid arthritis|ra|RA|Rheumatoid arthritis | Rheumatoid Arthritis |
C0049482 | null | aminohexane bisphosphonate|Neridronate|6-AHHDP|neridronate|AHHexBP|6-amino-1-hydroxyhexylidene-1,1-bisphosphonic acid | 6-amino-1-hydroxyhexane-1,1-diphosphonate |
C0019994 | Institutions with an organized medical staff which provide medical care to patients. | Hospitals|HOSPITAL|Hospital, NOS|hospital|hospitals|Hospital|hospital environment | Hospitals |
C0003662 | The clear, watery fluid which fills the anterior and posterior chambers of the eye. It has a refractive index lower than the crystalline lens, which it surrounds, and is involved in the metabolism of the cornea and the crystalline lens. (Cline et al., Dictionary of Visual Science, 4th ed, p319) | intraocular fluid|Humor aquosus|Aqueous humor of eyeball|Aqueous humor|Structure of aqueous humor|Aqueous Humors|Humors, Aqueous|EYE, AQUEOUS HUMOR|Intraocular Fluid|Fluids, Intraocular|Intraocular Fluids|aqueous humour|Aqueous Humour|Aqueous humour|Aqueous Humor|AQUEOUS HUMOR|Structure of aqueous humor (body structure)|aqueous humor|Structure of aqueous humour|Portion of aqueous humor|Aqueous humor (substance)|Humor, Aqueous|Fluid, Intraocular | Aqueous Humor |
C0012860 | Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. | Injuries, DNA|dna damage|DNA, injury to|Deoxyribonucleic acid damage (finding)|Damages, DNA|damage dna|DNA Injury|DNA Injuries|Damage, DNA|Injury, DNA|DNA Damage|DNA Damages|DNA injury|DNA damage|Deoxyribonucleic acid damage | DNA Damage |
C1175175 | A viral respiratory infection caused by the SARS coronavirus. It is transmitted through close person-to-person contact. It is manifested with high fever, headache, dry cough and myalgias. It may progress to pneumonia and cause death. | SARS-CoV infection|Respiratory Syndrome, Acute, Severe|SARS (Severe Acute Respiratory Syndrome)|Severe acute respiratory syndrome|Respiratory Syndrome, Severe Acute|severe acute respiratory syndrome (SARS)|SARS-associated coronavirus|Severe acute respiratory syndrome (disorder)|SARS|Coronavirus Infections|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome | Severe Acute Respiratory Syndrome |
C0039751 | Unlawful act of taking property. | Thefts|steal|Stealing|steals|theft|thief|Theft|Theft (finding)|stealing|Stealings|thefts | Theft |
C0618927 | null | 1-Heptanaminium, N,N,N-triheptyl-, (OC-6-22)-1,4-butanediyltetraiodotellurate(2-) (2:1)|TACT | bis(tetraheptylammonium)tetraiodocyclopentane tellurate(IV) |
C0241845 | null | COMBATIVE | combative |
C0087086 | null | THROMBI|Clots, Blood|Thrombi|Blood Clots|Thrombotic|thrombus|Thrombus|blood clot|Thrombus, NOS|thrombi|Thrombus (morphologic abnormality)|Blood Clot|Clot, Blood | Thrombus |
C0162578 | Surgical removal of an obstructing clot or foreign material from a blood vessel at the point of its formation. Removal of a clot arising from a distant site is called EMBOLECTOMY. | Removal of thrombus (procedure)|Thrombectomy, NOS|thrombectomy|Thrombectomy|Removal of thrombus, NOS|Thrombectomies|Removal of thrombus | Thrombectomy |
C0162860 | The artery supplying nearly all the left half of the transverse colon, the whole of the descending colon, the sigmoid colon, and the greater part of the rectum. It is smaller than the superior mesenteric artery (MESENTERIC ARTERY, SUPERIOR) and arises from the aorta above its bifurcation into the common iliac arteries. | Inferior Mesenteric Arteries|Inferior mesenteric arterial tree|Arteria mesenterica inferior|Inferior mesenteric artery|inferior mesenteric artery|Arteries, Inferior Mesenteric|mesenteric inferior artery|Structure of inferior mesenteric artery|Mesenteric Artery, Inferior|Inferior Mesenteric Artery|Inferior mesenteric artery structure|Structure of inferior mesenteric artery (body structure)|Artery, Inferior Mesenteric|Mesenteric Arteries, Inferior | Structure of inferior mesenteric artery |
C0162861 | A large vessel supplying the whole length of the small intestine except the superior part of the duodenum. It also supplies the cecum and the ascending part of the colon and about half the transverse part of the colon. It arises from the anterior surface of the aorta below the celiac artery at the level of the first lumbar vertebra. | Superior Mesenteric Arteries|SMA - Superior mesenteric artery|artery mesenteric superior|Superior Mesenteric Artery|Arteria mesenterica superior|superior mesenteric artery|Superior mesenteric artery structure (body structure)|Mesenteric Artery, Superior|Artery, Superior Mesenteric|Superior mesenteric artery|Superior mesenteric arterial tree|Arteries, Superior Mesenteric|Mesenteric Arteries, Superior|Superior mesenteric artery structure | Superior mesenteric artery structure |
C1267336 | null | Entire right renal artery|Entire right renal artery (body structure) | Entire right renal artery |
C1267337 | null | Entire left renal artery|Entire left renal artery (body structure) | Entire left renal artery |
C0399975 | null | ileal bypass|Bypass of ileum (procedure) | Bypass of ileum |
C0149750 | An operation to remove all or part of the colon through a long incision made in the wall of the abdomen. When only part of the colon is removed, it is called a partial colectomy. | colectomy partial|PARTIAL COLECTOMY|Partial Colectomy|Partial colectomy|Segmental colectomy|Subtotal colectomy|STC - Subtotal colectomy|Partial resection of colon (procedure)|Partial Resection of Colon|Partial Excision of Colon|subtotal colectomy|open colectomy|partial colectomy|Subtotal Colectomy|Partial resection of colon|Segmental excision of colon|partial colon resection | Partial resection of colon |
C0015809 | The vein accompanying the femoral artery in the same sheath; it is a continuation of the popliteal vein and becomes the external iliac vein. | femoral veins|Vein, Femoral|Veins, Femoral|Femoral vein structure|VEIN, FEMORAL|Femoral Vein|FEMORAL VEIN|Femoral Veins|Femoral vein structure (body structure)|Femoral vein|Vena femoralis|femoral vein|Femoral vein, NOS | Femoral vein |
C1181642 | Any artery arising from the deep femoral artery. | Subdivision of deep femoral artery|Deep Femoral Artery Branch|Deep femoral arterial subdivision|Branch of deep femoral artery | Subdivision of deep femoral artery |
C1269018 | null | Entire profunda femoris artery|Entire profunda femoris artery (body structure)|Entire PFA - Profunda femoris artery | Entire profunda femoris artery |
C0442037 | null | popliteal|Popliteal (qualifier value)|Popliteal | Popliteal |
C1522577 | Monitoring a person's health over time after treatment. This includes keeping track of the health of people who participate in a clinical study or clinical trial for a period of time, both during the study and after the study ends. | Follow Up|Active Follow-up|follow-up|Follow-Up|Follow-up|Followup|Clinical Signs Follow-up|CLSFUP | follow-up |
C0279516 | A substance that kills bacteria or stops them from growing and causing disease. | Anti-Bacterial Compounds|antibacterial drugs|Substance with antibacterial mechanism of action (substance)|Anti Bacterial Compounds|antibacterial|anti-bacterial agents|Antibacterial agent|Agents, Antibacterial|Antibacterial Agent|Antibacterial, NOS|antibacterial agent|Compounds, Anti-Bacterial|Antibacterial Agent [TC]|Agents, Anti-Bacterial|Anti Bacterial Agents|Antibacterials|Antibacterial Agents|Medicinal product acting as antibacterial agent (product)|antibacterial drug|Substance with antibacterial mechanism of action|Antibacterial|antibacterial agents|antibacterials|Anti-Bacterial Agents | Anti-Bacterial Agents |
C0023916 | Reptiles within the order Squamata that generally possess limbs, moveable EYELIDS, and EXTERNAL EAR openings, although there are some species which lack one or more of these structures. | Lizard (organism)|lizard|Lizard|SUBORDER SAURIA - LIZARDS|lizards|Lizards|Lizard, NOS|Suborder sauria - lizard | Lizards |
C0006357 | A species of the true toads, Bufonidae, becoming fairly common in the southern United States and almost pantropical. The secretions from the skin glands of this species are very toxic to animals. | giant toad|Toads, Marine|Giant toad|Rhinella marina|cane toad|Marine Toads|Bufo marinus|Toad, Marine|Toad, Giant|Bufo marinus (organism)|Marine toad|Cane toad|Toads, Giant|Giant Toad|Rhinella marina (organism)|Chaunus marinus|Giant Toads|Marine Toad|Rana marina | Bufo marinus |
C0002092 | Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). | Allergen (attribute)|ALLERGENS|allergen|Allergen|Allergens|allergens | Allergens |
C0155877 | null | Asthma, allergic|allergic asthma|Allergic asthma|Extrinsic asthma|asthma extrinsic|atopic asthma|asthma allergic|asthma atopic|Atopic asthma|Allergic asthma (disorder)|extrinsic asthma|Asthma, allergic NOS|Asthma, atopic | Allergic asthma |
C0027430 | Focal accumulations of EDEMA fluid in the NASAL MUCOSA accompanied by HYPERPLASIA of the associated submucosal connective tissue. Polyps may be NEOPLASMS, foci of INFLAMMATION, degenerative lesions, or malformations. | Nasal polyposis|polyps nasal|cavity nasal polyps|Polyp of nasal cavity, NOS|Polyps, Nasal|nasal polyposis|Polyp of the Nasal Cavity|Nasal Cavity Polyp|Nasal polyp, NOS|Unspecified nasal polyp|nasal polyps|NOSE POLYP|nose polyp|Polyp of Nasal Cavity|Nasal polyp NOS|Nasal polyps|Polyp, Nasal|nose polyps|nasals polyps|polyp nasal|NOSE, POLYP|Polyp of nasal cavity|polyposis nasal|NASAL POLYP|Polyp of nasal cavity (disorder)|Polys of nose|NASAL POLYPOSIS|nasal polyp|Nasal Polyp|POLYPS NASAL|Nasal polyp | Nasal Polyps |
C0333390 | null | Chronic eosinophilic inflammation, NOS|Chronic eosinophilic inflammation (morphologic abnormality) | Chronic eosinophilic inflammation |
C0002103 | Allergic rhinitis with a positive skin prick test (SPT equal or greater than 3 mm) to any allergen. | Atopic Rhinitis|Atopic rhinitis|RHINITIS, ATOPIC | Atopic rhinitis |
C0741250 | null | null | aspirin sensitivity |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.